We pinpoint divergent RUNX2 activity within the two populations as a potential driver of differential function and show that ectopic expression of RUNX2 enhances the anti-leukemia response and mediates exhaustion resistance in CAR T cells in a manner dependent on prior T cell antigen experience status. Here, RUNX2 is linked to leukemia.